↓ Skip to main content

C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice

Overview of attention for article published in Frontiers in immunology, October 2020
Altmetric Badge

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice
Published in
Frontiers in immunology, October 2020
DOI 10.3389/fimmu.2020.575154
Pubmed ID
Authors

Nirmal K. Banda, Stephen Tomlinson, Robert I. Scheinman, Nhu Ho, Joseline Ramos Ramirez, Gaurav Mehta, Guankui Wang, Vivian Pham Vu, Dmitri Simberg, Liudmila Kulik, V. Michael Holers

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 17%
Researcher 3 17%
Student > Doctoral Student 2 11%
Other 1 6%
Professor > Associate Professor 1 6%
Other 0 0%
Unknown 8 44%
Readers by discipline Count As %
Medicine and Dentistry 3 17%
Veterinary Science and Veterinary Medicine 2 11%
Immunology and Microbiology 2 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Other 0 0%
Unknown 9 50%